These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36852556)
1. Novel phytochemical inhibitors targeting monkeypox virus thymidine and serine/threonine kinase: integrating computational modeling and molecular dynamics simulation. Patel M; Bazaid AS; Azhar EI; Gattan HS; Binsaleh NK; Patel M; Surti M; Adnan M J Biomol Struct Dyn; 2023; 41(23):13679-13695. PubMed ID: 36852556 [TBL] [Abstract][Full Text] [Related]
2. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development. Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027 [TBL] [Abstract][Full Text] [Related]
3. Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses. Ali SI; Salama A Adv Exp Med Biol; 2024; 1451():337-354. PubMed ID: 38801589 [TBL] [Abstract][Full Text] [Related]
4. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel potential inhibitors of monkeypox virus thymidine kinase using molecular docking, molecular dynamics simulation and MM/PBSA methods. Abdizadeh T Mol Divers; 2023 Jul; ():. PubMed ID: 37462851 [TBL] [Abstract][Full Text] [Related]
6. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis. Sib Tul Hassan Shah S; Naeem I J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852 [TBL] [Abstract][Full Text] [Related]
7. A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus. Hossain FMA; Bappy MNI; Robin TB; Ahmad I; Patel H; Jahan N; Rabbi MGR; Roy A; Chowdhury W; Ahmed N; Prome AA; Rani NA; Khan P; Zinnah KMA J Biomol Struct Dyn; 2024 Aug; 42(12):6091-6107. PubMed ID: 37403283 [TBL] [Abstract][Full Text] [Related]
8. Machine learning and classical MD simulation to identify inhibitors against the P37 envelope protein of monkeypox virus. Rout M; Dey S; Mishra S; Panda S; Singh MK; Sinha R; Dehury B; Pati S J Biomol Struct Dyn; 2024 May; 42(8):3935-3948. PubMed ID: 37221882 [TBL] [Abstract][Full Text] [Related]
9. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy. Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954 [TBL] [Abstract][Full Text] [Related]
10. Identifying potential monkeypox virus inhibitors: an Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508 [TBL] [Abstract][Full Text] [Related]
11. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents. Yang L; Mo X; Yang H; Dai H; Tan F J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898 [TBL] [Abstract][Full Text] [Related]
12. Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies. Mohammad T; Siddiqui S; Shamsi A; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan MI Molecules; 2020 Feb; 25(4):. PubMed ID: 32070031 [TBL] [Abstract][Full Text] [Related]
13. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I. Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105 [TBL] [Abstract][Full Text] [Related]
15. Identification of a high affinity selective inhibitor of Polo-like kinase 1 for cancer chemotherapy by computational approach. Kumar M; Pydi SP; Sharma S; Singh TP; Kaur P J Mol Graph Model; 2014 Jun; 51():104-12. PubMed ID: 24879322 [TBL] [Abstract][Full Text] [Related]
17. Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease. Bhattacharjee A; Ahammad I; Chowdhury ZM; Das KC; Keya CA; Salimullah M Mol Biotechnol; 2024 Apr; 66(4):626-640. PubMed ID: 36357534 [TBL] [Abstract][Full Text] [Related]
18. Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus. Ali Y; Imtiaz H; Tahir MM; Gul F; Saddozai UAK; Ur Rehman A; Ren ZG; Khattak S; Ji XY Viruses; 2023 Feb; 15(2):. PubMed ID: 36851785 [TBL] [Abstract][Full Text] [Related]
19. Vaccinomics to design a multi-epitope-based vaccine against monkeypox virus using surface-associated proteins. Khan S; Irfan M; Hameed AR; Ullah A; Abideen SA; Ahmad S; Haq MU; El Bakri Y; Al-Harbi AI; Ali M; Haleem A J Biomol Struct Dyn; 2023 Dec; 41(20):10859-10868. PubMed ID: 36533379 [TBL] [Abstract][Full Text] [Related]
20. Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer. Mohammad T; Arif K; Alajmi MF; Hussain A; Islam A; Rehman MT; Hassan I J Biomol Struct Dyn; 2021 Feb; 39(2):586-594. PubMed ID: 31903847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]